Compass Therapeutics, Inc. (CMPX)
2.52
+0.12
(+5.00%)
USD |
NASDAQ |
Aug 25, 16:00
2.52
0.00 (0.00%)
After-Hours: 17:22
Compass Therapeutics Price : 2.52 for Aug. 25, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 24, 2026 | 2.42 | 2.43 | 2.32 | 2.40 | 974876.0 |
| Aug 21, 2026 | 2.39 | 2.45 | 2.33 | 2.40 | 2.032M |
| Aug 20, 2026 | 2.42 | 2.455 | 2.31 | 2.36 | 2.179M |
| Aug 19, 2026 | 2.42 | 2.52 | 2.41 | 2.48 | 3.903M |
| Aug 18, 2026 | 2.275 | 2.44 | 2.24 | 2.39 | 2.934M |
| Aug 17, 2026 | 2.20 | 2.37 | 2.20 | 2.31 | 2.369M |
| Aug 14, 2026 | 2.30 | 2.30 | 2.23 | 2.25 | 1.362M |
| Aug 13, 2026 | 2.36 | 2.37 | 2.23 | 2.26 | 2.272M |
| Aug 12, 2026 | 2.20 | 2.385 | 2.165 | 2.37 | 8.291M |
| Aug 11, 2026 | 2.20 | 2.38 | 2.20 | 2.20 | 3.985M |
| Aug 10, 2026 | 2.15 | 2.23 | 2.11 | 2.22 | 4.206M |
| Aug 07, 2026 | 2.05 | 2.175 | 2.03 | 2.15 | 3.827M |
| Aug 06, 2026 | 1.93 | 2.00 | 1.87 | 1.99 | 6.689M |
| Aug 05, 2026 | 2.00 | 2.01 | 1.85 | 1.89 | 4.253M |
| Aug 04, 2026 | 1.90 | 2.00 | 1.89 | 1.98 | 3.050M |
| Aug 03, 2026 | 1.94 | 1.95 | 1.85 | 1.885 | 3.511M |
| Jul 31, 2026 | 1.95 | 1.96 | 1.86 | 1.91 | 2.641M |
| Jul 30, 2026 | 1.93 | 1.959 | 1.91 | 1.94 | 1.913M |
| Jul 29, 2026 | 2.04 | 2.04 | 1.94 | 1.94 | 3.176M |
| Jul 28, 2026 | 2.07 | 2.08 | 1.97 | 2.04 | 3.148M |
| Jul 27, 2026 | 2.11 | 2.225 | 2.08 | 2.08 | 3.402M |
| Jul 24, 2026 | 2.12 | 2.14 | 2.060 | 2.07 | 1.590M |
| Jul 23, 2026 | 2.02 | 2.14 | 1.99 | 2.12 | 2.267M |
| Jul 22, 2026 | 2.09 | 2.11 | 2.00 | 2.04 | 1.772M |
| Jul 21, 2026 | 2.02 | 2.10 | 2.01 | 2.10 | 1.621M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Upstream Bio, Inc. | 7.18 |
| ACADIA Pharmaceuticals, Inc. | 30.58 |
| Alnylam Pharmaceuticals, Inc. | 239.95 |
| Anika Therapeutics, Inc. | 21.52 |
| Savara, Inc. | 5.59 |
Price Related Metrics
| Price to Book Value | 2.733 |
| Earnings Yield | -15.97% |
| Market Cap | 453.82M |